161 related articles for article (PubMed ID: 7582562)
1. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats.
Yan QS; Jobe PC; Dailey JW
Br J Pharmacol; 1995 Aug; 115(7):1314-8. PubMed ID: 7582562
[TBL] [Abstract][Full Text] [Related]
2. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Yan QS; Jobe PC; Cheong JH; Ko KH; Dailey JW
Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):149-52. PubMed ID: 7527501
[TBL] [Abstract][Full Text] [Related]
3. The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study.
Dailey JW; Seo DO; Yan QS; Ko KH; Jo M; Jobe PC
Neurosci Lett; 1994 Sep; 178(2):179-83. PubMed ID: 7529909
[TBL] [Abstract][Full Text] [Related]
4. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Yan QS; Jobe PC; Dailey JW
Eur J Pharmacol; 1994 Jan; 252(1):105-12. PubMed ID: 8149989
[TBL] [Abstract][Full Text] [Related]
5. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
Dailey JW; Yan QS; Mishra PK; Burger RL; Jobe PC
J Pharmacol Exp Ther; 1992 Feb; 260(2):533-40. PubMed ID: 1738103
[TBL] [Abstract][Full Text] [Related]
6. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo.
Rollema H; Clarke T; Sprouse JS; Schulz DW
J Neurochem; 1996 Nov; 67(5):2204-7. PubMed ID: 8863532
[TBL] [Abstract][Full Text] [Related]
7. Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis.
Yan QS; Jobe PC; Dailey JW
Brain Res; 1993 Apr; 610(1):24-31. PubMed ID: 8518928
[TBL] [Abstract][Full Text] [Related]
8. Neither intranigral fluoxetine nor 5,7-dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats.
Statnick M; Dailey J; Jobe P; Browning R
Eur J Pharmacol; 1996 Mar; 299(1-3):93-102. PubMed ID: 8901011
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).
Dailey JW; Yan QS; Adams-Curtis LE; Ryu JR; Ko KH; Mishra PK; Jobe PC
Life Sci; 1996; 58(4):259-66. PubMed ID: 8538363
[TBL] [Abstract][Full Text] [Related]
10. Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
Rutter JJ; Auerbach SB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1319-24. PubMed ID: 7685386
[TBL] [Abstract][Full Text] [Related]
11. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
Yan QS; Mishra PK; Burger RL; Bettendorf AF; Jobe PC; Dailey JW
J Pharmacol Exp Ther; 1992 May; 261(2):652-9. PubMed ID: 1374472
[TBL] [Abstract][Full Text] [Related]
12. Localization of the serotonergic terminal fields modulating seizures in the genetically epilepsy-prone rat.
Merrill MA; Clough RW; Dailey JW; Jobe PC; Browning RA
Epilepsy Res; 2007 Sep; 76(2-3):93-102. PubMed ID: 17689928
[TBL] [Abstract][Full Text] [Related]
13. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
Caccia S; Anelli M; Codegoni AM; Fracasso C; Garattini S
Br J Pharmacol; 1993 Sep; 110(1):355-9. PubMed ID: 7693282
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.
Sprouse J; Clarke T; Reynolds L; Heym J; Rollema H
Neuropsychopharmacology; 1996 Apr; 14(4):225-31. PubMed ID: 8924190
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats.
Graumlich JF; McLaughlin RG; Birkhahn D; Shah N; Burk A; Jobe PC; Dailey JW
Eur J Pharmacol; 1999 Mar; 369(3):305-11. PubMed ID: 10225367
[TBL] [Abstract][Full Text] [Related]
16. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
Mishra PK; Kahle EH; Bettendorf AF; Dailey JW; Jobe PC
Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.
Browning RA; Wood AV; Merrill MA; Dailey JW; Jobe PC
Eur J Pharmacol; 1997 Oct; 336(1):1-6. PubMed ID: 9384247
[TBL] [Abstract][Full Text] [Related]
19. Periaqueductal gray neurons exhibit increased responsiveness associated with audiogenic seizures in the genetically epilepsy-prone rat.
N'Gouemo P; Faingold CL
Neuroscience; 1998 May; 84(2):619-25. PubMed ID: 9539230
[TBL] [Abstract][Full Text] [Related]
20. Basal and stimulated extracellular serotonin concentration in the brain of rats with altered serotonin uptake.
Romero L; Jernej B; Bel N; Cicin-Sain L; Cortés R; Artigas F
Synapse; 1998 Apr; 28(4):313-21. PubMed ID: 9517840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
